发布求助
文献互助 智能选刊 最新文献

Seminars in Interventional Radiology最新文献

筛选
英文 中文
SBRT for Liver Tumors: What the Interventional Radiologist Needs to Know. 肝脏肿瘤的 SBRT 治疗：介入放射医师须知。
IF 1.4 4区 医学
Seminars in Interventional Radiology Pub Date : 2024-03-14 eCollection Date: 2024-02-01 DOI: 10.1055/s-0043-1778657
Michael J Gutman, Lucas M Serra, Matthew Koshy, Rohan R Katipally
{"title":"SBRT for Liver Tumors: What the Interventional Radiologist Needs to Know.","authors":"Michael J Gutman, Lucas M Serra, Matthew Koshy, Rohan R Katipally","doi":"10.1055/s-0043-1778657","DOIUrl":"10.1055/s-0043-1778657","url":null,"abstract":"<p><p>This review summarizes the clinical evidence supporting the utilization of stereotactic body radiotherapy (SBRT) for liver tumors, including hepatocellular carcinoma, liver metastases, and cholangiocarcinoma. Emerging prospective evidence has demonstrated the benefit and low rates of toxicity across a broad range of clinical contexts. We provide an introduction for the interventional radiologist, with a discussion of underlying themes such as tumor dose-response, mitigation of liver toxicity, and the technical considerations relevant to performing liver SBRT. Ultimately, we recommend that SBRT should be routinely included in the armamentarium of locoregional therapies for liver malignancies, alongside those liver-directed therapies offered by interventional radiology.</p>","PeriodicalId":48689,"journal":{"name":"Seminars in Interventional Radiology","volume":"41 1","pages":"1-10"},"PeriodicalIF":1.4,"publicationDate":"2024-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10940045/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140144356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Embolic Agents: Sclerotherapy. 栓塞剂硬化疗法
IF 1.4 4区 医学
Seminars in Interventional Radiology Pub Date : 2024-03-14 eCollection Date: 2024-02-01 DOI: 10.1055/s-0043-1778656
Christina Lim, Sean Lee, Abheek Ghosh, Brian Funaki
{"title":"Embolic Agents: Sclerotherapy.","authors":"Christina Lim, Sean Lee, Abheek Ghosh, Brian Funaki","doi":"10.1055/s-0043-1778656","DOIUrl":"10.1055/s-0043-1778656","url":null,"abstract":"","PeriodicalId":48689,"journal":{"name":"Seminars in Interventional Radiology","volume":"41 1","pages":"79-83"},"PeriodicalIF":1.4,"publicationDate":"2024-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10940036/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140144405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Yttrium-90 Radioembolization Dosimetry: Dose Considerations, Optimization, and Tips. 钇-90 放射性栓塞剂量测定：剂量考虑因素、优化和提示。
IF 1.4 4区 医学
Seminars in Interventional Radiology Pub Date : 2024-03-14 eCollection Date: 2024-02-01 DOI: 10.1055/s-0044-1779715
Alexander Villalobos, Johannes L du Pisanie, Ripal T Gandhi, Nima Kokabi
{"title":"Yttrium-90 Radioembolization Dosimetry: Dose Considerations, Optimization, and Tips.","authors":"Alexander Villalobos, Johannes L du Pisanie, Ripal T Gandhi, Nima Kokabi","doi":"10.1055/s-0044-1779715","DOIUrl":"10.1055/s-0044-1779715","url":null,"abstract":"","PeriodicalId":48689,"journal":{"name":"Seminars in Interventional Radiology","volume":"41 1","pages":"63-78"},"PeriodicalIF":1.4,"publicationDate":"2024-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10940044/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140144358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Techniques to Optimize Radioembolization Tumor Coverage. 优化放射栓塞肿瘤覆盖范围的技术。
IF 1 4区 医学
Seminars in Interventional Radiology Pub Date : 2024-03-14 eCollection Date: 2024-02-01 DOI: 10.1055/s-0043-1778659
M Kasim Fassia, Resmi Ann Charalel
{"title":"Techniques to Optimize Radioembolization Tumor Coverage.","authors":"M Kasim Fassia, Resmi Ann Charalel","doi":"10.1055/s-0043-1778659","DOIUrl":"10.1055/s-0043-1778659","url":null,"abstract":"<p><p>Yttrium-90 (Y90) radioembolization has become a major locoregional treatment option for several primary and secondary liver cancers. Understanding the various factors that contribute to optimal tumor coverage including sphere count, embolization techniques, and catheter choice is important for all interventional radiologists while planning Y90 dosimetry and delivery. Here, we review these factors and the evidence supporting current practice paradigms.</p>","PeriodicalId":48689,"journal":{"name":"Seminars in Interventional Radiology","volume":"41 1","pages":"16-19"},"PeriodicalIF":1.0,"publicationDate":"2024-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10940038/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140144357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biologics, Immunotherapies, and Cytotoxic Chemotherapy for Hepatocellular Carcinoma following Current Recommendations by the BCLC: A Review of Agents. 生物制剂、免疫疗法和细胞毒性化疗治疗肝细胞癌，遵循 BCLC 目前的建议：药物综述》。
IF 1.4 4区 医学
Seminars in Interventional Radiology Pub Date : 2024-03-14 eCollection Date: 2024-02-01 DOI: 10.1055/s-0043-1778660
Rajangad S Gurtatta, Sydney E Whalen, Charles E Ray
{"title":"Biologics, Immunotherapies, and Cytotoxic Chemotherapy for Hepatocellular Carcinoma following Current Recommendations by the BCLC: A Review of Agents.","authors":"Rajangad S Gurtatta, Sydney E Whalen, Charles E Ray","doi":"10.1055/s-0043-1778660","DOIUrl":"10.1055/s-0043-1778660","url":null,"abstract":"","PeriodicalId":48689,"journal":{"name":"Seminars in Interventional Radiology","volume":"41 1","pages":"84-91"},"PeriodicalIF":1.4,"publicationDate":"2024-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10940041/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140144403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Practical Considerations When Choosing Chemoembolization versus Radioembolization for Hepatocellular Carcinoma. 选择化疗栓塞还是放射栓塞治疗肝细胞癌的实际考虑因素。
IF 1.4 4区 医学
Seminars in Interventional Radiology Pub Date : 2024-03-14 eCollection Date: 2024-02-01 DOI: 10.1055/s-0044-1779714
Ashkan Heshmatzadeh Behzadi, Leila Haghani, Donna L D'Souza, Siobhan Flanagan, Christopher Jones
{"title":"Practical Considerations When Choosing Chemoembolization versus Radioembolization for Hepatocellular Carcinoma.","authors":"Ashkan Heshmatzadeh Behzadi, Leila Haghani, Donna L D'Souza, Siobhan Flanagan, Christopher Jones","doi":"10.1055/s-0044-1779714","DOIUrl":"10.1055/s-0044-1779714","url":null,"abstract":"<p><p>Transarterial chemoembolization (TACE) and transarterial radioembolization (TARE) are common liver-directed therapies (LDTs) for unresectable HCC. While both deliver intra-arterial treatment directly to the site of the tumor, they differ in mechanisms of action and side effects. Several studies have compared their side effect profile, time to progression, and overall survival data, but often these lack practical considerations when choosing which treatment modality to use. Many factors can impact operator's choice for treatment, and the choice depends on treatment availability, cost, insurance coverage, operator's comfort level, patient-specific factors, tumor location, tumor biology, and disease stage. This review discusses survival data, time to progression data, as well as more practical patient and tumor characteristics for personalized LDT with TACE or TARE.</p>","PeriodicalId":48689,"journal":{"name":"Seminars in Interventional Radiology","volume":"41 1","pages":"48-55"},"PeriodicalIF":1.4,"publicationDate":"2024-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10940042/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140144355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chemoembolization Beyond Hepatocellular Carcinoma: What Tumors Can We Treat and When? 化疗栓塞疗法超越肝细胞癌：我们能治疗哪些肿瘤，何时治疗？
IF 1 4区 医学
Seminars in Interventional Radiology Pub Date : 2024-03-14 eCollection Date: 2024-02-01 DOI: 10.1055/s-0043-1777716
Daniel M DePietro, Xin Li, Susan M Shamimi-Noori
{"title":"Chemoembolization Beyond Hepatocellular Carcinoma: What Tumors Can We Treat and When?","authors":"Daniel M DePietro, Xin Li, Susan M Shamimi-Noori","doi":"10.1055/s-0043-1777716","DOIUrl":"10.1055/s-0043-1777716","url":null,"abstract":"<p><p>Liver metastases are the most common malignancy found in the liver and are 20 to 40 times more common than primary hepatic tumors, including hepatocellular carcinoma. Patients with liver metastases often present with advanced disease and are not eligible for curative-intent surgery or ablative techniques. The unique hepatic arterial blood supply of liver metastases allows interventional radiologists to target these tumors with transarterial therapies. Transarterial chemoembolization (TACE) has been studied in the treatment of liver metastases originating from a variety of primary malignancies and has demonstrated benefits in terms of hepatic progression-free survival, overall survival, and symptomatic relief, among other benefits. Depending on the primary tumor from which they originate, liver metastases may have different indications for TACE, may utilize different TACE regimens and techniques, and may result in different post-procedural outcomes. This review offers an overview of TACE techniques and specific considerations in the treatment of liver metastases, provides an in-depth review of TACE in the treatment of liver metastases originating from colorectal cancer, neuroendocrine tumor, and uveal melanoma, which represent some of the many tumors beyond hepatocellular carcinoma that can be treated by TACE, and summarizes data regarding when one should consider TACE in their treatment algorithms.</p>","PeriodicalId":48689,"journal":{"name":"Seminars in Interventional Radiology","volume":"41 1","pages":"27-47"},"PeriodicalIF":1.0,"publicationDate":"2024-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10940046/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140144404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunoembolization for the Treatment of Uveal Melanoma Hepatic Metastases. 免疫栓塞治疗葡萄膜黑色素瘤肝转移。
IF 1.4 4区 医学
Seminars in Interventional Radiology Pub Date : 2024-03-14 eCollection Date: 2024-02-01 DOI: 10.1055/s-0043-1777712
Carin F Gonsalves
{"title":"Immunoembolization for the Treatment of Uveal Melanoma Hepatic Metastases.","authors":"Carin F Gonsalves","doi":"10.1055/s-0043-1777712","DOIUrl":"10.1055/s-0043-1777712","url":null,"abstract":"<p><p>Uveal melanoma is the most common primary intraocular tumor in adults. Approximately 50% of patients develop metastatic disease despite successful treatment of the primary eye tumor. The liver is the most common site of metastatic disease occurring in more than 90% of patients. Clinical prognosis is dependent on the ability to control the growth of liver tumors. Locoregional therapies play an important role in stabilizing liver metastases, prolonging survival for patients with metastatic uveal melanoma. As overall survival is prolonged, the development of extrahepatic disease becomes more common. Immunoembolization, a form of liver-directed therapy, not only focuses on treating hepatic metastases by stimulating the local immune system to suppress the growth of liver tumors, but it potentially generates a systemic immune response delaying the growth of extrahepatic metastases as well. The following article discusses immunoembolization for the treatment of metastatic uveal melanoma including the rationale, mechanism of action, indications, contraindications, outcomes, and associated toxicities.</p>","PeriodicalId":48689,"journal":{"name":"Seminars in Interventional Radiology","volume":"41 1","pages":"20-26"},"PeriodicalIF":1.4,"publicationDate":"2024-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10940043/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140144407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Simple "Involute" Technique for Successful Removal of a Caudally Migrated "Viatorr" Stent Graft. 成功移除尾部移位的 "Viatorr "支架移植物的简单 "内卷 "技术。
IF 1.4 4区 医学
Seminars in Interventional Radiology Pub Date : 2024-03-14 eCollection Date: 2024-02-01 DOI: 10.1055/s-0044-1779710
Vellia Zhou, Mark Reddick, Daniel Lamus, Ronald S Arellano, Sanjeeva P Kalva
{"title":"A Simple \"Involute\" Technique for Successful Removal of a Caudally Migrated \"Viatorr\" Stent Graft.","authors":"Vellia Zhou, Mark Reddick, Daniel Lamus, Ronald S Arellano, Sanjeeva P Kalva","doi":"10.1055/s-0044-1779710","DOIUrl":"10.1055/s-0044-1779710","url":null,"abstract":"","PeriodicalId":48689,"journal":{"name":"Seminars in Interventional Radiology","volume":"41 1","pages":"92-96"},"PeriodicalIF":1.4,"publicationDate":"2024-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10940037/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140144401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advanced Imaging Techniques Used in Direct Portosystemic Shunt Creation in Budd-Chiari Syndrome with Complex Venous Anatomy. 复杂静脉解剖的 Budd-Chiari 综合征直接门静脉分流术中使用的先进成像技术。
IF 1.4 4区 医学
Seminars in Interventional Radiology Pub Date : 2024-03-14 eCollection Date: 2024-02-01 DOI: 10.1055/s-0044-1779712
Sara Rostami, Jaclyn Fickert, Connor Morris, Michael Samuel, Doan Vu, Charles E Ray, Ali Kord
{"title":"Advanced Imaging Techniques Used in Direct Portosystemic Shunt Creation in Budd-Chiari Syndrome with Complex Venous Anatomy.","authors":"Sara Rostami, Jaclyn Fickert, Connor Morris, Michael Samuel, Doan Vu, Charles E Ray, Ali Kord","doi":"10.1055/s-0044-1779712","DOIUrl":"10.1055/s-0044-1779712","url":null,"abstract":"","PeriodicalId":48689,"journal":{"name":"Seminars in Interventional Radiology","volume":"41 1","pages":"97-102"},"PeriodicalIF":1.4,"publicationDate":"2024-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10940039/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140144402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信